This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
09 Days
Publication after acceptance
03 Days
*Last 12 months
Viewed By 6729 |
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment |
Viewed By 5769 |
MAFLD: How is it different from NAFLD? |
Viewed By 5530 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 4844 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Viewed By 4469 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 169 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 108 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma |
Cited By 108 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 80 |
MAFLD: How is it different from NAFLD? |
Cited By 77 |
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach |